Hydrogen-rich saline protects against liver injury in rats with obstructive jaundice

Liver Int. 2010 Aug;30(7):958-68. doi: 10.1111/j.1478-3231.2010.02254.x. Epub 2010 May 21.

Abstract

Background: Hydrogen selectively reduces levels of hydroxyl radicals and alleviates acute oxidative stress in many models. Hydrogen-rich saline provides a high concentration of hydrogen that can be easily and safely applied.

Aims: In this study, we investigated the effects of hydrogen-rich saline on the prevention of liver injury induced by obstructive jaundice in rats.

Methods: Male Sprague-Dawley rats (n=56) were divided randomly into four experimental groups: sham operated, bile duct ligation (BDL) plus saline treatment [5 ml/kg, intraperitoneal (i.p.)], BDL plus low-dose hydrogen-rich saline treatment (5 ml/kg, i.p.) and BDL plus high-dose hydrogen-rich saline treatment (10 ml/kg, i.p.).

Results: The liver damage was evaluated microscopically 10 days after BDL. Serum alanine aminotransferase and aspartate aminotransferase levels, tissue malondialdehyde content, myeloperoxidase activity, tumour necrosis factor-alpha, interleukin (IL)-1beta, IL-6 and high-mobility group box 1 levels were all increased significantly by BDL. Hydrogen-rich saline reduced levels of these markers and relieved morphological liver injury. Additionally, hydrogen-rich saline markedly increased the activities of anti-oxidant enzymes superoxide dismutase and catalase and downregulated extracellular signal-regulated protein kinase (ERK)1/2 activation.

Conclusions: Hydrogen-rich saline attenuates BDL-induced liver damage, possibly by the reduction of inflammation and oxidative stress and the inhibition of the ERK1/2 pathway.

MeSH terms

  • Alanine Transaminase / blood
  • Animals
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / pharmacology*
  • Antioxidants / administration & dosage
  • Antioxidants / pharmacology*
  • Aspartate Aminotransferases / blood
  • Catalase / metabolism
  • Cytoprotection
  • Disease Models, Animal
  • Endotoxins / blood
  • HMGB1 Protein / metabolism
  • Hydrogen / administration & dosage
  • Hydrogen / pharmacology*
  • Injections, Intraperitoneal
  • Interleukin-1beta / metabolism
  • Interleukin-6 / metabolism
  • Jaundice, Obstructive / complications
  • Jaundice, Obstructive / drug therapy*
  • Jaundice, Obstructive / metabolism
  • Jaundice, Obstructive / pathology
  • Liver / drug effects*
  • Liver / metabolism
  • Liver / pathology
  • Liver Diseases / etiology
  • Liver Diseases / metabolism
  • Liver Diseases / pathology
  • Liver Diseases / prevention & control*
  • Male
  • Malondialdehyde / metabolism
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3 / metabolism
  • Peroxidase / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Sodium Chloride / administration & dosage
  • Sodium Chloride / pharmacology*
  • Superoxide Dismutase / metabolism
  • Time Factors
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Anti-Inflammatory Agents
  • Antioxidants
  • Endotoxins
  • HMGB1 Protein
  • Hbp1 protein, rat
  • Interleukin-1beta
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • Sodium Chloride
  • Malondialdehyde
  • Hydrogen
  • Catalase
  • Peroxidase
  • Superoxide Dismutase
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3